As all the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our notable papers in the field of metabolic reprogramming in the tumor microenvironment, which are listed below:

1. “A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages”
by Iseulys Richert, Paul Berchard, Lhorra Abbes, Alexey Novikov, Kamel Chettab, Alexandra Vandermoeten, Charles Dumontet, Marie Karanian, Jerome Kerzerho, Martine Caroff et al.
Cancers 2023, 15(18), 4635; https://doi.org/10.3390/cancers15184635
Available online: https://www.mdpi.com/2072-6694/15/18/4635

2. “Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy”
by Julieta Afonso, Céline Gonçalves, Marta Costa, Débora Ferreira, Lúcio Santos, Adhemar Longatto-Filho and Fátima Baltazar
Cancers 2023, 15(3), 982; https://doi.org/10.3390/cancers15030982
Available online: https://www.mdpi.com/2072-6694/15/3/982

3. “Empowering the Potential of CAR-T Cell Immunotherapies by Epigenetic Reprogramming”
by Maria Alvanou, Memnon Lysandrou, Panayota Christophi, Nikoleta Psatha, Alexandros Spyridonidis, Anastasia Papadopoulou and Evangelia Yannaki
Cancers 2023, 15(7), 1935; https://doi.org/10.3390/cancers15071935
Available online: https://www.mdpi.com/2072-6694/15/7/1935

4. “Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification”
by Jyotirmayee Talapatra and Mamatha M. Reddy
Cancers 2023, 15(7), 2144; https://doi.org/10.3390/cancers15072144
Available online: https://www.mdpi.com/2072-6694/15/7/2144

5. “Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance”
by Pan Lei, Wenzhou Wang, Marisela Sheldon, Yutong Sun, Fan Yao and Li Ma
Cancers 2023, 15(13), 3390; https://doi.org/10.3390/cancers15133390
Available online: https://www.mdpi.com/2072-6694/15/13/3390

6. “Obesity Is Associated with Immunometabolic Changes in Adipose Tissue That May Drive Treatment Resistance in Breast Cancer: Immune-Metabolic Reprogramming and Novel Therapeutic Strategies”
by Constantinos Savva, Ellen Copson, Peter W. M. Johnson, Ramsey I. Cutress and Stephen A. Beers
Cancers 2023, 15(9), 2440; https://doi.org/10.3390/cancers15092440
Available online: https://www.mdpi.com/2072-6694/15/9/2440

7. “Reprogramming of the Genome-Wide DNA Methylation Landscape in Three-Dimensional Cancer Cell Cultures”
by Alma Jaqueline Heredia-Mendez, Gricelda Sánchez-Sánchez and César López-Camarillo
Cancers 2023, 15(7), 1991; https://doi.org/10.3390/cancers15071991
Available online: https://www.mdpi.com/2072-6694/15/7/1991

8. “Intestinal Epithelial Cells Adapt to Chronic Inflammation through Partial Genetic Reprogramming”
by Guillaume Collin, Jean-Philippe Foy, Nicolas Aznar, Nicolas Rama, Anne Wierinckx, Pierre Saintigny, Alain Puisieux and Stéphane Ansieau
Cancers 2023, 15(3), 973; https://doi.org/10.3390/cancers15030973
Available online: https://www.mdpi.com/2072-6694/15/3/973

9. “Metabolic Reprogramming in Colon Cancer Cells Persistently Infected with Newcastle Disease Virus”
by Tong Yu, Archana Chandrabhan Jadhav, Jiabao Xu, Adrian L. Harris, Venugopal Nair and Wei E. Huang
Cancers 2023, 15(3), 811; https://doi.org/10.3390/cancers15030811
Available online: https://www.mdpi.com/2072-6694/15/3/811

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office